ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Ponatinib Dosing Regimen Demonstrates Improved Responses, Survival in Patients With CP-CML"
Episode Synopsis
Jorge Cortes, MD, shares findings from the OPTIC trial on a dosing regimen of ponatinib for patients with CP-CML. These data are being presented at the 2021 ASCO Annual Meeting.
In God we trust